NasdaqCM - Nasdaq Real Time Price USD
CERo Therapeutics Holdings, Inc. (CEROW)
0.0120
+0.0020
+(20.00%)
As of 9:58:55 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-11,699.2430
-5,789.9870
-11,709.3110
-10,094.3800
Investing Cash Flow
--
--
-694.2320
-612.5660
Financing Cash Flow
12,240.6820
571.6780
5.6250
60.2550
End Cash Position
3,103.4640
1,601.2550
6,819.5640
19,217.4820
Capital Expenditure
--
--
-694.2320
-612.5660
Issuance of Capital Stock
7,961.6640
--
--
--
Issuance of Debt
408.0520
605.2300
--
--
Free Cash Flow
-11,699.2430
-5,789.9870
-12,403.5430
-10,706.9460
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRMAW Dermata Therapeutics, Inc.
0.0236
-7.81%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0179
+23.45%
SRZNW Surrozen, Inc.
0.0276
+70.37%
COMBI.ST CombiGene AB (publ)
2.4300
+0.83%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
NLSPW NLS Pharmaceutics AG
0.0033
-15.38%
KMSTF Kadimastem Ltd
5.06
0.00%
APLMW Apollomics, Inc.
0.0077
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0300
0.00%